Patents by Inventor Jeegar P. Patel

Jeegar P. Patel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump Inhibitors
    Publication number: 20240350493
    Abstract: The present disclosure relates to the co-administration of Belumosudil with CYP3A Inducers and/or Proton Pump Inhibitors for use in the treatment of subjects with chronic graft-versus-host disease (cGVHD).
    Type: Application
    Filed: April 24, 2024
    Publication date: October 24, 2024
    Applicant: Kadmon Corporation, LLC
    Inventors: Olivier Schueller, Jeegar P. Patel
  • Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient Subpopulations
    Publication number: 20240277713
    Abstract: The present disclosure provides methods of administering belumosudil mesylate salt to certain subpopulations of patients with cGVHD.
    Type: Application
    Filed: March 27, 2024
    Publication date: August 22, 2024
    Applicant: Kadmon Corporation, LLC
    Inventor: Jeegar P. Patel
  • Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host Disease
    Publication number: 20240262810
    Abstract: The present disclosure provides metabolites of belumosudil and uses of the metabolites in of treating patients with ROCK2-mediated diseases including cGVHD.
    Type: Application
    Filed: March 5, 2024
    Publication date: August 8, 2024
    Applicant: Kadmon Corporation, LLC
    Inventors: Olivier Schueller, Jeegar P. Patel
  • Belumosudil metabolites and uses thereof in the treatment of chronic graft-versus-host disease
    Patent number: 11952369
    Abstract: The present disclosure provides metabolites of belumosudil and uses of the metabolites in of treating patients with ROCK2-mediated diseases including cGVHD.
    Type: Grant
    Filed: February 3, 2023
    Date of Patent: April 9, 2024
    Assignee: Kadmon Corporation, LLC
    Inventors: Olivier Schueller, Jeegar P. Patel
  • Methods of Administering Belumosudil for Treatment of Chronic Graft Versus Host Disease in Patient Subpopulations
    Publication number: 20240024323
    Abstract: The present disclosure provides methods of administering belumosudil mesylate salt to certain subpopulations of patients with cGVHD.
    Type: Application
    Filed: February 3, 2023
    Publication date: January 25, 2024
    Applicant: Kadmon Corporation, LLC
    Inventor: Jeegar P. Patel
  • Methods of Administering Belumosudil in Combination with CYP3A Inducers and/or Proton Pump Inhibitors
    Publication number: 20240024322
    Abstract: The present disclosure relates to the co-administration of Belumosudil with CYP3A Inducers and/or Proton Pump Inhibitors for use in the treatment of subjects with chronic graft-versus-host disease (cGVHD).
    Type: Application
    Filed: February 3, 2023
    Publication date: January 25, 2024
    Applicant: Kadmon Corporation, LLC
    Inventors: Olivier Schueller, Jeegar P. Patel
  • Belumosudil Metabolites and Uses Thereof In The Treatment of Chronic Graft-Versus-Host Disease
    Publication number: 20240025881
    Abstract: The present disclosure provides metabolites of belumosudil and uses of the metabolites in of treating patients with ROCK2-mediated diseases including cGVHD.
    Type: Application
    Filed: February 3, 2023
    Publication date: January 25, 2024
    Applicant: Kadmon Corporation, LLC
    Inventors: Olivier Schueller, Jeegar P. Patel
  • Anti-PD-1 Antibodies and Fusion Proteins
    Publication number: 20230416363
    Abstract: Provided herein are recombinant antibodies, antigen-binding fragments, and fusion proteins thereof useful for binding to and inhibiting programmed death 1 (PD-1), nucleic acid molecules encoding the same and therapeutic compositions thereof, as well as methods of using such antibodies, including the methods for enhancing T cell and NK cell function to increase cell and cytokine mediated immunity and methods of treatment of various immune dysfunction related disorders including cancer and infectious diseases.
    Type: Application
    Filed: June 23, 2021
    Publication date: December 28, 2023
    Applicant: Kadmon Corporation, LLC
    Inventors: Dan Lu, Zhanna Polonskaya, Tzu-Pei Chang, Stella Aviaty Martomo, Jeegar P. Patel, Faical Miyara
  • Methods of Treating Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
    Publication number: 20230381179
    Abstract: The present disclosure relates generally to the treatment of patients with chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplantation by administering belumosudil at certain dosages.
    Type: Application
    Filed: April 18, 2023
    Publication date: November 30, 2023
    Applicant: Kadmon Corporation, LLC
    Inventors: Sanjay Aggarwal, Mark Berger, David Eiznhamer, Jeegar P. Patel, Olivier Schueller
  • B7-H4 Antibodies and Anti-B7-H4 Antibody/IL-15 Fusion Proteins
    Publication number: 20230312724
    Abstract: Provided herein are recombinant antibodies, antigen-binding fragments thereof, and fusion proteins thereof useful for binding to and inhibiting B7-H4. Also provided are nucleic acid molecules encoding the antibodies, antigen-binding fragments thereof, and fusion proteins thereof disclosed herein and therapeutic compositions thereof. Disclosed are further methods of using the disclosed antibodies, antigen-binding fragments thereof, and fusion proteins thereof for the treatment of disease.
    Type: Application
    Filed: November 29, 2022
    Publication date: October 5, 2023
    Applicant: Kadmon Corporation, LLC
    Inventors: Dan Lu, Jeegar P. Patel, Tzu-Pei Chang, Zhanna Polonskaya, Faical Miyara